Skip to main content
SpringerLink
Log in

Interactions between CRF and acetylcholine in the modulation of cognitive behaviour

  • Chapter
Book cover Neurotransmitter Interactions and Cognitive Function

Part of the book series: Experientia Supplementum ((EXS,volume 98))

  • 1169 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rivier CL, Plotsky PM (1986) Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol 48: 475–494

    PubMed  CAS  Google Scholar 

  2. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394–1397

    PubMed  CAS  Google Scholar 

  3. De Souza EB (1995) Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20: 789–819

    PubMed  Google Scholar 

  4. Dunn AJ, Berridge CW (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 15: 71–100

    PubMed  CAS  Google Scholar 

  5. Steckler T, Holsboer F (1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46: 1480–1508

    PubMed  CAS  Google Scholar 

  6. Zorrilla EP, Koob GF (2005) The roles of Urocortins 1, 2 and 3 in the brain. In: Steckler T, Kalin NH, Reul JMHM (eds): Handbook of stress and the rain. Elsevier, Amsterdam, 179–203

    Google Scholar 

  7. Chang CP, Pearse RV, O’Connell S, Rosenfeld MG(1993) Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11: 1187–1195

    PubMed  CAS  Google Scholar 

  8. Chen R, Lewis KA, Perrin MH, Vale WW (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90: 8967–8971

    PubMed  CAS  Google Scholar 

  9. Kishimoto T, Pearse RV, Lin CR, Rosenfeld MG (1995) A sauvagine/corticotropinreleasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92: 1108–1112

    PubMed  CAS  Google Scholar 

  10. Kostich WA, Chen A, Sperle K, Largent BL (1998) Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol Endocrinol 12: 1077–1085

    PubMed  CAS  Google Scholar 

  11. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, De Souza EB (1996) Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137: 72–77

    PubMed  CAS  Google Scholar 

  12. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza E B, Oltersdorf T (1995) Cloning and characterization of a functionally distinct corticotropinreleasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92: 836–840

    PubMed  CAS  Google Scholar 

  13. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW (1993) Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133: 3058–3061

    PubMed  CAS  Google Scholar 

  14. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P, Vale W (1995) Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92: 2969–2973

    PubMed  CAS  Google Scholar 

  15. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB, Stenzel-Poore MP (1995) Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 9: 637–645

    PubMed  CAS  Google Scholar 

  16. Valdenaire O, Giller T, Breu V, Gottowik J, Kilpatrick G (1997) A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochim Biophys Acta 1352: 129–132

    PubMed  CAS  Google Scholar 

  17. Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M, Le Fur G, Caput D, Ferrara P (1993) Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 335: 1–5

    PubMed  CAS  Google Scholar 

  18. Lovenberg TW, Chalmers DT, Liu, C, De Souza EB (1995) CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136: 4139–4142

    PubMed  CAS  Google Scholar 

  19. Sauvage M, Steckler T (2001) Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei-potential implication for arousal and attention. Neuroscience 104: 643–652

    PubMed  CAS  Google Scholar 

  20. Merchenthaler I (1984) Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 5: Suppl-69

    Google Scholar 

  21. Merchenthaler I, Vigh S, Schally AV, Stumpf WE, Arimura A (1984) Immunocytochemical localization of corticotropin releasing factor (CRF)-like immunoreactivity in the thalamus of the rat. Brain Res 323: 119–122

    PubMed  CAS  Google Scholar 

  22. Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR (1999) Differential distribution of urocortin-and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 92: 281–291

    PubMed  CAS  Google Scholar 

  23. Sakanaka M, Shibasaki T, Lederis K (1987) Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J Comp Neurol 260: 256–298

    PubMed  CAS  Google Scholar 

  24. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36: 165–186

    PubMed  CAS  Google Scholar 

  25. Van Bockstaele EJ, Colago EE, Valentino RJ (1996) Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 364: 523–534

    PubMed  Google Scholar 

  26. Bremner JD, Krystal JH, Southwick SM, Charney DS (1996) Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23: 28–38

    PubMed  CAS  Google Scholar 

  27. Valentino RJ, Page M, Van Bockstaele E, Aston-Jones G (1992) Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input. Neuroscience 48: 689–705

    PubMed  CAS  Google Scholar 

  28. Van Bockstaele EJ, Colago EE, Valentino RJ (1998) Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol 10: 743–757

    PubMed  Google Scholar 

  29. Koegler-Muly SM, Owens MJ, Ervin GN, Kilts CD, Nemeroff CB (1993) Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 5: 95–98

    PubMed  CAS  Google Scholar 

  30. Valentino RJ, Foote SL, Page ME (1993) The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann NY Acad Sci 697: 173–188

    PubMed  CAS  Google Scholar 

  31. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287–292

    PubMed  CAS  Google Scholar 

  32. Hsu SY, Hsueh AJ (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7: 605–611

    PubMed  CAS  Google Scholar 

  33. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W et al. (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98: 7570–7575

    PubMed  CAS  Google Scholar 

  34. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98: 2843–2848

    PubMed  CAS  Google Scholar 

  35. Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE (1999) Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 415: 285–312

    PubMed  CAS  Google Scholar 

  36. Kozicz T, Yanaihara H, Arimura A (1998) Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 391: 1–10

    PubMed  CAS  Google Scholar 

  37. Butcher LL (1995) Cholinergic neurons and networks. In: Paxinos G (ed) The rat nervous system. Academic Press, San Diego, 1003–1015

    Google Scholar 

  38. Aston-Jones G, Shipley MT, Grzanna R (1995) The Locus Coeruleus, A5 and A7 Noradrenergic Cell Groups. In: Paxinos G (ed) The rat central nervous system, Academic Press, San Diego, 183–213

    Google Scholar 

  39. Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM (2003) International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands. Pharmacol Rev 55: 21–26

    PubMed  CAS  Google Scholar 

  40. Mesulam MM, Mufson EJ, Wainer BH, Levey AI (1983) Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1–Ch6). Neuroscience 10: 1185–1201

    PubMed  CAS  Google Scholar 

  41. Hellendall RP, Godfrey DA, Ross CD, Armstrong DM, Price JL (1986) The distribution of choline acetyltransferase in the rat amygdaloid complex and adjacent cortical areas, as determined by quantitative micro-assay and immunohistochemistry. J Comp Neurol 249: 486–498

    PubMed  CAS  Google Scholar 

  42. Satoh K, Fibiger HC (1986) Cholinergic neurons of the laterodorsal tegmental nucleus: efferent and afferent connections. J Comp Neurol 253: 277–302

    PubMed  CAS  Google Scholar 

  43. Steckler T, Inglis W, Winn P, Sahgal A (1994) The pedunculopontine tegmental nucleus: a role in cognitive processes? Brain Res Brain Res Rev 19: 298–318

    PubMed  CAS  Google Scholar 

  44. Picciotto MR, Caldarone BJ, King SL, Zachariou V (2000) Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 22: 451–465

    PubMed  CAS  Google Scholar 

  45. Han ZY, Zoli M, Cardona A, Bourgeois JP, Changeux JP, Le Novere N (2003) Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta. J Comp Neurol 461: 49–60

    PubMed  CAS  Google Scholar 

  46. Happe HK, Peters JL, Bergman DA, Murrin LC (1994) Localization of nicotinic cholinergic receptors in rat brain: autoradiographic studies with [3H]cytisine. Neuroscience 62: 929–944

    PubMed  CAS  Google Scholar 

  47. McGehee DS, Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57: 521–546

    PubMed  CAS  Google Scholar 

  48. Rowell PP, Winkler DL (1984) Nicotinic stimulation of [3H]acetylcholine release from mouse cerebral cortical synaptosomes. J Neurochem 43: 1593–1598

    PubMed  CAS  Google Scholar 

  49. Volpicelli LA, Levey AI (2004) Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 145: 59–66

    PubMed  CAS  Google Scholar 

  50. Spencer DG Jr., Horvath E, Traber J (1986) Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections. Brain Res 380: 59–68

    PubMed  CAS  Google Scholar 

  51. Carey GJ, Billard W, Binch H, III, Cohen-Williams M, Crosby G, Grzelak M, Guzik H, Kozlowski JA, Lowe DB, Pond AJ et al. (2001) SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. Eur J Pharmacol 431: 189–200

    PubMed  CAS  Google Scholar 

  52. Stillman MJ, Shukitt-Hale B, Galli RL, Levy A, Lieberman HR (1996) Effects of M2 antagonists on in vivo hippocampal acetylcholine levels. Brain Res Bull 41: 221–226

    PubMed  CAS  Google Scholar 

  53. Tzavara ET, Bymaster FP, Felder CC, Wade M, Gomeza J, Wess J, McKinzie DL, Nomikos GG (2003) Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice. Mol Psychiatry 8: 673–679

    PubMed  CAS  Google Scholar 

  54. Regenold W, Araujo DM, Quirion R (1989) Quantitative autoradiographic distribution of [3H]AF-DX 116 muscarinic-M2 receptor binding sites in rat brain. Synapse 4: 115–125

    PubMed  CAS  Google Scholar 

  55. Bymaster FP, Heath I, Hendrix JC, Shannon HE (1993) Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J Pharmacol Exp Ther 267: 16–24

    PubMed  CAS  Google Scholar 

  56. Gallagher M, Holland PC (1994) The amygdala complex: multiple roles in associative learning and attention. Proc Natl Acad Sci USA 91: 11771–11776

    PubMed  CAS  Google Scholar 

  57. Garcia-Rill E (1991) The Pedunculopontine Nucleus. Prog Neurobiol 36: 363–389

    PubMed  CAS  Google Scholar 

  58. Muir JL, Dunnett SB, Robbins TW, Everitt BJ (1992) Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp Brain Res 89: 611–622

    PubMed  CAS  Google Scholar 

  59. Muir JL, Everitt BJ, Robbins TW (1994) AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 14: 2313–2326

    PubMed  CAS  Google Scholar 

  60. Muir JL, Everitt BJ, Robbins TW (1996) The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex 6: 470–481

    PubMed  CAS  Google Scholar 

  61. Overton P, Dean P (1988) Detection of visual stimuli after lesions of the superior colliculus in the rat; deficit not confined to the far periphery. Behav Brain Res 31: 1–15

    PubMed  CAS  Google Scholar 

  62. Robbins TW, Everitt BJ, Marston HM, Wilkinson J, Jones GH, Page KJ (1989) Comparative effects of ibotenic acid-and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav Brain Res 35: 221–240

    PubMed  CAS  Google Scholar 

  63. Crawley JN, Olschowka JA, Diz DI, Jacobowitz DM (1985) Behavioral investigation of the coexistence of substance P, corticotropin releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat. Peptides 6: 891–901

    PubMed  CAS  Google Scholar 

  64. Austin MC, Rice PM, Mann JJ, Arango V (1995) Localization of corticotropin-releasing hormone in the human locus coeruleus and pedunculopontine tegmental nucleus: an immunocytochemical and in situ hybridization study. Neuroscience 64: 713–727

    PubMed  CAS  Google Scholar 

  65. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9: 361–380

    PubMed  CAS  Google Scholar 

  66. Cole BJ, Robbins TW (1992) Forebrain norepinephrine: role in controlled information processing in the rat. Neuropsychopharmacology 7: 129–142

    PubMed  CAS  Google Scholar 

  67. Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G (1999) The role of locus coeruleus in the regulation of cognitive performance. Science 283: 549–554

    PubMed  CAS  Google Scholar 

  68. Butler PD, Weiss JM, Stout JC, Nemeroff CB (1990) Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10: 176–183

    PubMed  CAS  Google Scholar 

  69. Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Nakazato A, Kumagai T, Okubo T, Tomisawa K (1999) Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. J Pharmacol Exper Ther 289: 926–935

    CAS  Google Scholar 

  70. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T et al. (1996) CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 93: 10477–10482

    PubMed  CAS  Google Scholar 

  71. Day JC, Koehl M, Deroche V, Le Moal M, Maccari S (1998) Prenatal stress enhances stress-and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release in adult rats. J Neurosci 18: 1886–1892

    PubMed  CAS  Google Scholar 

  72. Day JC, Koehl M, Le Moal M, Maccari S (1998) Corticotropin-releasing factor administered centrally, but not peripherally, stimulates hippocampal acetylcholine release. J Neurochem 71: 622–629

    PubMed  CAS  Google Scholar 

  73. Desvignes C, Rouquier L, Souilhac J, Mons G, Rodier D, Soubrie P, Steinberg R (2003) Control by tachykinin NK(2) receptors of CRF(1) receptor-mediated activation of hippocampal acetylcholine release in the rat and guinea-pig. Neuropeptides 37: 89–97

    PubMed  CAS  Google Scholar 

  74. Gully D, Geslin M, Serva L, Fontaine E, Roger P, Lair C, Darre V, Marcy C, Rouby P E, Simiand J et al. (2002) 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical ad pharmacological characterization. J Pharmacol Exp Ther 301: 322–332

    PubMed  CAS  Google Scholar 

  75. Bittencourt JC, Sawchenko PE (2000) Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J Neurosci 20: 1142–1156

    PubMed  CAS  Google Scholar 

  76. Lai H, Carino MA (1990) Effects of noise on high-affinity choline uptake in the frontal cortex and hippocampus of the rat are blocked by intracerebroventricular injection of corticotropin-releasing factor antagonist. Brain Res 527: 354–358

    PubMed  CAS  Google Scholar 

  77. Hess C, Blozovski D (1987) Hippocampal muscarinic cholinergic mediation of spontaneous alternation and fear in the developing rat. Behav Brain Res 24: 203–214

    PubMed  CAS  Google Scholar 

  78. Smythe JW, Colom LV, Bland BH (1992) The extrinsic modulation of hippocampal theta depends on the coactivation of cholinergic and GABA-ergic medial septal inputs. Neurosci Biobehav Rev 16: 289–308

    PubMed  CAS  Google Scholar 

  79. Bhatnagar S, Costall B, Smythe JW (1997) Hippocampal cholinergic blockade enhances hypothalamic-pituitary-adrenal responses to stress. Brain Res 766: 244–248

    PubMed  CAS  Google Scholar 

  80. Acquas E, Wilson C, Fibiger HC (1996) Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. J Neurosci 16: 3089–3096

    PubMed  CAS  Google Scholar 

  81. Gilad GM, Mahon BD, Finkelstein Y, Koffler B, Gilad VH (1985) Stress-induced activation of the hippocampal cholinergic system and the pituitary-adrenocortical axis. Brain Res 347: 404–408

    PubMed  CAS  Google Scholar 

  82. Imperato A, Puglisi-Allegra S, Casolini P, Angelucci L (1991) Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res 538: 111–117

    PubMed  CAS  Google Scholar 

  83. Onali P, Olianas MC (1998) Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex. J Pharmacol Exp Ther 286: 753–759

    PubMed  CAS  Google Scholar 

  84. De Souza EB, Battaglia G (1986) Increased corticotropin-releasing factor receptors in rat cerebral cortex following chronic atropine treatment. Brain Res 397: 401–404

    PubMed  Google Scholar 

  85. Raber J, Koob GF, Bloom FE (1995) Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J Pharmacol Exp Ther 272: 815–824

    PubMed  CAS  Google Scholar 

  86. Pitkanen A, Savander V, LeDoux JE (1997) Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci 20: 517–523

    PubMed  CAS  Google Scholar 

  87. Okada S, Shimizu T, Yokotani K (2003) Extrahypothalamic corticotropin-releasing hormone mediates (-)-nicotine-induced elevation of plasma corticosterone in rats. Eur J Pharmacol 473: 217–223

    PubMed  CAS  Google Scholar 

  88. Ohmori N, Itoi K, Tozawa F, Sakai Y, Sakai K, Horiba N, Demura H, Suda T (1995) Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Endocrinology 136: 4858–4863

    PubMed  CAS  Google Scholar 

  89. Han JS, Bizon JL, Chun HJ, Maus CE, Gallagher M (2002) Decreased glucocorticoid receptor mRNA and dysfunction of HPA axis in rats after removal of the cholinergic innervation to hippocampus. Eur J Neurosci 16: 1399–1404

    PubMed  Google Scholar 

  90. Ehlers CL, Reed TK, Henriksen SJ (1986) Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 42:467–474

    PubMed  CAS  Google Scholar 

  91. Arai K, Ohata H, Shibasaki T (1998) Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1. Neurosci Lett 255: 103–106

    PubMed  CAS  Google Scholar 

  92. Chang FC, Opp MR (1998) Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat. Am J Physiol 275: R793–R802

    PubMed  CAS  Google Scholar 

  93. Chang FC, Opp MR (2004) A corticotropin-releasing hormone antisense oligodeoxynucleotide reduces spontaneous waking in the rat. Regul Pept 117: 43–52

    PubMed  CAS  Google Scholar 

  94. Kita I, Seki Y, Nakatani Y, Fumoto M, Oguri M, Sato-Suzuki I, Arita H (2006) Corticotropin-releasing factor neurons in the hypothalamic paraventricular nucleus are involved in arousal/yawning response of rats. Behav Brain Res 169: 48–56

    PubMed  CAS  Google Scholar 

  95. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW (1994) Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 14: t–84

    Google Scholar 

  96. van Gaalen MM, Reul JH, Gesing A, Stenzel-Poore MP, Holsboer F, Steckler T (2002) Mice overexpressing CRH show reduced responsiveness in plasma corticosterone after a5-HT1A receptor challenge. Genes Brain Behav 1: 174–177

    PubMed  Google Scholar 

  97. van Gaalen MM, Stenzel-Poore M, Holsboer F, Steckler T (2003) Reduced attention in mice overproducing corticotropin-releasing hormone. Behav Brain Res 142: 69–79

    PubMed  Google Scholar 

  98. Inglis WL, Olmstead MC, Robbins TW (2001) Selective deficits in attentional performance on the 5-choice serial reaction time task following pedunculopontine tegmental nucleus lesions. Behav Brain Res 123: 117–131

    PubMed  CAS  Google Scholar 

  99. Zorrilla EP, Schulteis G, Ormsby A, Klaassen A, Ling N, McCarthy JR, Koob GF, De Souza EB (2002) Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors. Brain Res 952: 200–210

    PubMed  CAS  Google Scholar 

  100. Wang HL, Wayner MJ, Chai CY, Lee EH (1998) Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur J Neurosci 10:3428–3437

    PubMed  CAS  Google Scholar 

  101. Wang HL, Tsai LY, Lee EH (2000) Corticotropin-releasing factor produces a protein synthesis-dependent long-lasting potentiation in dentate gyrus neurons. J Neurophysiol 83: 343–349

    PubMed  CAS  Google Scholar 

  102. Blank T, Nijholt I, Eckart K, Spiess J (2002) Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J Neurosci 22: 3788–3794

    PubMed  CAS  Google Scholar 

  103. Blank T, Nijholt I, Grammatopoulos DK, Randeva HS, Hillhouse EW, Spiess J (2003) Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J Neurosci 23: 700–707

    PubMed  CAS  Google Scholar 

  104. Radulovic J, Ruhmann A, Liepold T, Spiess J (1999) Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 19: 5016–5025

    PubMed  CAS  Google Scholar 

  105. Hung HC, Chou CK, Chiu TH, Lee EH (1992) CRF increases protein phosphorylation and enhances retention performance in rats. Neuroreport 3: 181–184

    PubMed  CAS  Google Scholar 

  106. Lee EH, Hung HC, Lu KT, Chen WH, Chen HY (1992) Protein synthesis in the hippocampus associated with memory facilitation by corticotropin-releasing factor in rats. Peptides 13: 927–937

    PubMed  CAS  Google Scholar 

  107. Lee EH, Lee CP, Wang HI, Lin WR (1993) Hippocampal CRF, NE, and NMDA system interactions in memory processing in the rat. Synapse 14: 144–153

    PubMed  CAS  Google Scholar 

  108. Wu HC, Chen KY, Lee WY, Lee EH (1997) Antisense oligonucleotides to corticotropin-releasing factor impair memory retention and increase exploration in rats. Neuroscience 78: 147–153

    PubMed  CAS  Google Scholar 

  109. Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale W, Gold LH (1999) Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res 835: 1–9

    PubMed  CAS  Google Scholar 

  110. Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong ML, Chrousos GP, Webster E, Gold PW (1999) The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140: 79–86

    PubMed  CAS  Google Scholar 

  111. Hikichi T, Akiyoshi J, Yamamoto Y, Tsutsumi T, Isogawa K, Nagayama H (2000) Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526. Pharmacopsychiatry 33: 189–193

    PubMed  CAS  Google Scholar 

  112. Hogan JB, Hodges DB, Jr., Lelas S, Gilligan PJ, McElroy JF, Lindner MD (2005) Effects of CRF1 receptor antagonists and benzodiazepines in the Morriswater maze and delayed non-matching to position tests. Psychopharmacology (Berl) 178: 410–419

    CAS  Google Scholar 

  113. Liebsch G, Landgraf R, Engelmann M, Lorscher P, Holsboer F (1999) Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J Psychiatr Res 33: 153–163

    PubMed  CAS  Google Scholar 

  114. Maaswinkel H, Baars AM, Gispen WH, Spruijt BM (1996) Roles of the basolateral amygdala and hippocampus in social recognition in rats. Physiol Behav 60: 55–63

    PubMed  CAS  Google Scholar 

  115. Morris RG, Garrud P, Rawlins JN, O’Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297: 681–683

    PubMed  CAS  Google Scholar 

  116. Isogawa K, Akiyoshi J, Tsutsumi T, Kodama K, Horinouti Y, Nagayama H (2003) Anxiogenic-like effect of corticotropin-releasing factor receptor 2 antisense oligonucleotides infused into rat brain. J Psychopharmacol 17: 409–413

    PubMed  CAS  Google Scholar 

  117. Radulovic J, Fischer A, Katerkamp U, Spiess J (2000) Role of regional neurotransmitter receptors in corticotropin-releasing factor (CRF)-mediated modulation of fear conditioning. Neuropharmacology 39: 707–710

    PubMed  CAS  Google Scholar 

  118. Stiedl O, Meyer M, Jahn O, Ogren SO, Spiess J (2005) Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear. J Pharmacol Exp Ther 312: 905–916

    PubMed  CAS  Google Scholar 

  119. Telegdy G, Tiricz H, Adamik A (2005) Involvement of neurotransmitters in urocortin-induced passive avoidance learning in mice. Brain Res Bull 67: 242–247

    PubMed  CAS  Google Scholar 

  120. Klenerova V, Kaminsky O, Sida P, Hlinak Z, Krejci I, Hynie S (2003) Impaired passive avoidance acquisition in Wistar rats after restraint/cold stress and/or stresscopin administration. Gen Physiol Biophys 22: 115–120

    PubMed  CAS  Google Scholar 

  121. Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ (2002) Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci USA 99: 13908–13913

    PubMed  CAS  Google Scholar 

  122. Robison CL, Meyerhoff JL, Saviolakis GA, Chen WK, Rice KC, Lumley LA (2004) A CRH1 antagonist into the amygdala of mice prevents defeat-induced defensive behavior. Ann NY Acad Sci 1032: 324–327

    PubMed  CAS  Google Scholar 

  123. Behan DP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, De Souza EB (1995) Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer’s disease. Nature 378: 284–287

    PubMed  CAS  Google Scholar 

  124. Heinrichs SC, Vale EA, Lapsansky J, Behan DP, McClure LV, Ling N, De Souza EB, Schulteis G (1997) Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. Peptides 18: 711–716

    PubMed  CAS  Google Scholar 

  125. Zorrilla EP, Schulteis G, Ling N, Koob GF, De Souza EB (2001) Performance-enhancing effects of CRF-BP ligand inhibitors. Neuroreport 12: 1231–1234

    PubMed  CAS  Google Scholar 

  126. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW (1992) The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 89: 4192–4196

    PubMed  CAS  Google Scholar 

  127. Heinrichs SC (2003) Modulation of social learning in rats by brain corticotropin-releasing factor. Brain Res 994: 107–114

    PubMed  CAS  Google Scholar 

  128. Fenoglio KA, Brunson KL, Avishai-Eliner S, Stone BA, Kapadia BJ, Baram TZ (2005) Enduring, handling-evoked enhancement of hippocampal memory function and glucocorticoid receptor expression involves activation of the corticotropin-releasing factor type 1 receptor. Endocrinology 146: 4090–4096

    PubMed  CAS  Google Scholar 

  129. Fenoglio KA, Brunson KL, Avishai-Eliner S, Chen Y, Baram TZ (2004) Region-specific onset of handling-induced changes in corticotropin-releasing factor and glucocorticoid receptor expression. Endocrinology 145: 2702–2706

    PubMed  CAS  Google Scholar 

  130. Fenoglio KA, Chen Y, Baram TZ (2006) Neuroplasticity of the hypothalamic-pituitary-adrenal axis early in life requires recurrent recruitment of stress-regulating brain regions. J Neurosci 26: 2434–2442

    PubMed  CAS  Google Scholar 

  131. Jasnow AM, Davis M, Huhman KL (2004) Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral responses to social defeat. Behav Neurosci 118: 1052–1061

    PubMed  CAS  Google Scholar 

  132. Ruhmann A, Bonk I, Lin CR, Rosenfeld MG, Spiess J (1998) Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. Proc Natl Acad Sci USA 95: 15264–15269

    PubMed  CAS  Google Scholar 

  133. Cooper MA, Huhman KL (2005) Corticotropin-releasing factor type II (CRF-sub-2) receptors in the bed nucleus of the stria terminalis modulate conditioned defeat in Syrian hamsters (Mesocricetus auratus). Behav Neurosci 119: 1042–1051

    PubMed  Google Scholar 

  134. Sananbenesi F, Fischer A, Schrick C, Spiess J, Radulovic J (2003) Mitogen-activated protein kinase signaling in the hippocampus and its modulation by corticotropin-releasing factor receptor 2: a possible link between stress and fear memory. J Neurosci 23:11436–11443

    PubMed  CAS  Google Scholar 

  135. Steckler T, Holsboer F (2001) Interaction between the cholinergic system and CRH in the modulation of spatial discrimination learning in mice. Brain Res 906: 46–59

    PubMed  CAS  Google Scholar 

  136. Rivier J, Rivier C, Vale W (1984) Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science 224: 889–891

    PubMed  CAS  Google Scholar 

  137. Tucci S, Cheeta S, Seth P, File SE (2003) Corticotropin releasing factor antagonist, alpha-helical CRF(9–41), reverses nicotine-induced conditioned, but not unconditioned, anxiety. Psychopharmacology (Berl) 167: 251–256

    CAS  Google Scholar 

  138. Cheeta S, Kenny PJ, File SE (2000) Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 24: 1053–1067

    PubMed  CAS  Google Scholar 

  139. Li YH, Ku YH (2002) Involvement of rat lateral septum-acetylcholine pressor system in central amygdaloid nucleus-emotional pressor circuit. Neurosci Lett 323: 60–64

    PubMed  CAS  Google Scholar 

  140. Prickaerts J, Steckler T (2005) Effects of glucocorticoids on emotion and cognitive processes in animals. In: Steckler T, Kalin NH, and Reul JMHM (eds): Handbook of Stress and the Brain, Elsevier, Amsterdam, 359–385

    Google Scholar 

  141. Ingram CD (2005) Pathways and transmitter interactions mediating an integrated stress response. In: Steckler T, Kalin NH, Reul JMHM (eds): Handbook of Stress and the Brain, Elsevier, Amsterdam, 609–639

    Google Scholar 

  142. Sarter, M. (1994) Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? Psychopharmacology 114: 539–550

    PubMed  CAS  Google Scholar 

  143. Zobel AW, Schulze-Rauschenbach S, von Widdern OC, Metten M, Freymann N, Grasmader K, Pfeiffer U, Schnell S, Wagner M, Maier W (2004) Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment. J Psychiatr Res 38: 377–383

    PubMed  Google Scholar 

  144. Janowsky DS, Overstreet DH, Nurnberger JI, Jr. (1994) Is cholinergic sensitivity a genetic marker for the affective disorders? Am J Med Genet 54: 335–344

    PubMed  CAS  Google Scholar 

  145. Holmes A, Heilig M, Rupniak NMJ, Steckler T, Griebel G (2003) Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24: 580–588

    PubMed  CAS  Google Scholar 

  146. Butcher LL (1992) The cholinergic basal forebrain and its telencephalic targets: Interrelations and implications for cognitive function. In: Levin ED, Decker MW and Butcher LL (eds): Neurotransmitter interactions and cognitive function. Birkhäuser Verlag, Switzerland, pp. 15–26

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. Psychiatry, RED Europe, Johnson & Johnson Pharmaceutical Research and Development, Turnhoutseweg 30, 2340, Beerse, Belgium

    Geoff Warnock, Jos Prickaerts & Thomas Steckler

Authors
  1. Geoff Warnock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jos Prickaerts
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Steckler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Psychiatry and Behavioral Sciences Neurobehavioural Research Laboratory, Duke University Medical Center, Box 3412, Durham, NC, 27710, USA

    Edward D. Levin

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Warnock, G., Prickaerts, J., Steckler, T. (2006). Interactions between CRF and acetylcholine in the modulation of cognitive behaviour. In: Levin, E.D. (eds) Neurotransmitter Interactions and Cognitive Function. Experientia Supplementum, vol 98. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7772-4_3

Download citation

Publish with us

Policies and ethics

Search

Navigation